Π.Φ.Υ. στα νησιά...απλά πράγματα!!! Χρήστου Απ. Μαντά, Προέδρου ΙΣΡisrodoy isrΣυνδιάσκεψη του Δ.Σ. του Π.Ι.Σ.
με τους Προέδρους των Ιατρικών Συλλόγων της χώρας,
στην Κω το Σάββατο, 16 Σεπτεμβρίου 2017
με θέμα: «Πολιτική Υγείας στη νησιωτική Ελλάδα».
4 ΣΥΜΠΟΣΙΟ ΚΛΙΝΙΚΗΣ ΟΓΚΟΛΟΓΙΑΣ: Καρκίνος κεφαλής - τραχήλου, Εξατομικεύοντας ...isrodoy isrThe document discusses head and neck cancer, focusing on individualizing treatment. It notes that head and neck cancer incidence is increasing, with some caused by HPV. EGFR is a molecular target in these cancers. Studies combining EGFR inhibitors like cetuximab with chemoradiation in locally advanced disease showed increased toxicity but uncertain efficacy benefits. Biomarker-selected treatment de-intensification may be appropriate for HPV-positive cancers.
4 ΣΥΜΠΟΣΙΟ ΚΛΙΝΙΚΗΣ ΟΓΚΟΛΟΓΙΑΣ: Ακτινοθεραπεία στον καρκίνο του τραχήλου της ...isrodoy isrThis document discusses gastrointestinal stromal tumors (GIST) and the use of adjuvant imatinib therapy. It provides background on GIST epidemiology and risk factors for recurrence. Studies show adjuvant imatinib for 1 year after surgery significantly reduces recurrence rates compared to placebo, especially for high-risk patients. The SSGXVIII trial found adjuvant imatinib for 3 years further reduced recurrence rates compared to 1 year of treatment, with no significant difference in overall survival yet. Adjuvant imatinib for 3 years may provide additional benefit over 1 year, especially for high-risk GIST patients.
4 ΟΓΚΟΛΟΓΙΚΟ ΣΥΝΕΔΡΙΟ ΡΟΔΟΥisrodoy isrThis document provides information on the treatment of metastatic renal cell carcinoma. It discusses current targeted therapies for RCC including inhibitors of VEGF and mTOR pathways such as sunitinib, sorafenib, everolimus and temsirolimus. Patient outcomes with various first and second line targeted therapies are presented. Guidelines for cytoreductive nephrectomy and metastasectomy are also summarized.
4 ΟΓΚΟΛΟΓΙΚΟ ΣΥΝΕΔΡΙΟ ΡΟΔΟΥ: Προεγχειρητική χημειοθεραπεία στον καρκίνο του μ...isrodoy isr4 ΟΓΚΟΛΟΓΙΚΟ ΣΥΝΕΔΡΙΟ ΡΟΔΟΥ: Προεγχειρητική χημειοθεραπεία στον καρκίνο του μαστού.
4 ΟΓΚΟΛΟΓΙΚΟ ΣΥΝΕΔΡΙΟ ΡΟΔΟΥ: Surgical management axilla.isrodoy isrThis document summarizes the surgical management of the axilla, focusing on sentinel lymph node biopsy techniques. It discusses:
1. The axilla contains 3 levels of lymph nodes that are assessed during axillary surgery. Sentinel lymph node biopsy targets levels I-II.
2. Techniques for identifying sentinel nodes include radioactive tracing using radiocolloids and blue dye mapping. Combined hot and blue methods increase detection rates.
3. Complications of axillary surgery include seroma, lymphedema, infection, and limited arm mobility. Sentinel node biopsy reduces these risks compared to axillary dissection.
4. Ongoing research aims to further minimize the morbidity of axillary staging while
4 ΣΥΜΠΟΣΙΟ ΚΛΙΝΙΚΗΣ ΟΓΚΟΛΟΓΙΑΣ ΡΟΔΟΥ: Εξελίξεις στη θεραπεία του πλακώδους κα...isrodoy isrThe document discusses recent developments in the treatment of non-small cell lung cancer (NSCLC). It summarizes several key studies that have established new standards of care and treatment options for NSCLC. These include the use of pemetrexed or albumin-bound paclitaxel in combination with platinum chemotherapy as first-line options. Targeted therapies such as necitumumab for squamous cell NSCLC and the addition of bevacizumab or cetuximab to chemotherapy based on tumor biomarkers are also discussed. Studies establishing the role of the anti-VEGF antibody ramucirumab in combination with docetaxel in the second-line setting are summarized.
4 ΟΓΚΟΛΟΓΙΚΟ ΣΥΝΕΔΡΙΟ ΡΟΔΟΥisrodoy isrThis document provides information on the treatment of metastatic renal cell carcinoma. It discusses current targeted therapies for RCC including inhibitors of VEGF and mTOR pathways such as sunitinib, sorafenib, everolimus and temsirolimus. Patient outcomes with various first and second line targeted therapies are presented. Guidelines for cytoreductive nephrectomy and metastasectomy are also summarized.
4 ΟΓΚΟΛΟΓΙΚΟ ΣΥΝΕΔΡΙΟ ΡΟΔΟΥ: Προεγχειρητική χημειοθεραπεία στον καρκίνο του μ...isrodoy isr4 ΟΓΚΟΛΟΓΙΚΟ ΣΥΝΕΔΡΙΟ ΡΟΔΟΥ: Προεγχειρητική χημειοθεραπεία στον καρκίνο του μαστού.
4 ΟΓΚΟΛΟΓΙΚΟ ΣΥΝΕΔΡΙΟ ΡΟΔΟΥ: Surgical management axilla.isrodoy isrThis document summarizes the surgical management of the axilla, focusing on sentinel lymph node biopsy techniques. It discusses:
1. The axilla contains 3 levels of lymph nodes that are assessed during axillary surgery. Sentinel lymph node biopsy targets levels I-II.
2. Techniques for identifying sentinel nodes include radioactive tracing using radiocolloids and blue dye mapping. Combined hot and blue methods increase detection rates.
3. Complications of axillary surgery include seroma, lymphedema, infection, and limited arm mobility. Sentinel node biopsy reduces these risks compared to axillary dissection.
4. Ongoing research aims to further minimize the morbidity of axillary staging while
4 ΣΥΜΠΟΣΙΟ ΚΛΙΝΙΚΗΣ ΟΓΚΟΛΟΓΙΑΣ ΡΟΔΟΥ: Εξελίξεις στη θεραπεία του πλακώδους κα...isrodoy isrThe document discusses recent developments in the treatment of non-small cell lung cancer (NSCLC). It summarizes several key studies that have established new standards of care and treatment options for NSCLC. These include the use of pemetrexed or albumin-bound paclitaxel in combination with platinum chemotherapy as first-line options. Targeted therapies such as necitumumab for squamous cell NSCLC and the addition of bevacizumab or cetuximab to chemotherapy based on tumor biomarkers are also discussed. Studies establishing the role of the anti-VEGF antibody ramucirumab in combination with docetaxel in the second-line setting are summarized.
